Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Minnesota?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Minnesota resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Minnesota-licensed prescriber, or a physician holding a Minnesota interstate telehealth registration, including through telehealth. Minnesota Statutes section 151.37 requires a documented patient evaluation including an examination only for a listed set of drugs (controlled substances, muscle relaxants, opioid-type analgesics, butalbital products, and PDE5 inhibitors for erectile dysfunction), so GLP-1s and other peptides fall under the general standard of care instead. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Minnesota Board of Pharmacy, and out-of-state pharmacies that regularly ship into Minnesota need a nonresident pharmacy license under section 151.19.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Minnesota resident get peptides by telehealth?

Minn. Stat. section 147.033 says a physician-patient relationship may be established through telehealth and holds telehealth to the same standards of practice as in-person care. It borrows the telehealth definition in the Minnesota Telehealth Act, Minn. Stat. section 62A.673, subdivision 2. That definition first says telehealth is delivered through real time two-way interactive audio and visual communications, then says telehealth includes store-and-forward technology, and excludes patient communication that is solely email or fax. Minn. Stat. section 151.37, subdivision 2, makes a prescription invalid unless based on a documented patient evaluation including an examination, but only for the drugs listed in paragraph (d): controlled substances, Board-designated controlled substances, muscle relaxants, centrally acting analgesics with opioid activity, drugs containing butalbital, and PDE5 inhibitors for erectile dysfunction. Semaglutide, tirzepatide, and the other peptides in this database are not on that list, so prescribing them by telehealth is governed by the general standard of care. Physicians must hold a Minnesota license or an interstate telehealth registration under Minn. Stat. section 147.032. No Minnesota statute located says whether a questionnaire alone is enough. This record leaves asynchronous prescribing unconfirmed because the definition is ambiguous: one sentence requires real-time audio and video and the next includes store-and-forward, and nothing says which controls. [2] [3] [4] [5]

How does the Minnesota pharmacy board treat compounding?

Compounding regulator for Minnesota
BoardMinnesota Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The Minnesota Board of Pharmacy licenses pharmacies under Minn. Stat. chapter 151 (the Pharmacy Practice and Wholesale Distribution Act) and regulates practice through Minnesota Rules chapter 6800. Under section 151.19, a pharmacy located outside Minnesota that dispenses to Minnesota residents and ships prescription drugs into the state must hold a Minnesota nonresident pharmacy license, disclose its home-state licensure, and name the pharmacists dispensing to Minnesota patients; the Board also requires a nonresident pharmacist-in-charge designation. Minnesota has no state bulks list; peptide eligibility follows the federal 503A framework. The Board's published guidance documents and its compounding FAQ page, checked on 2026-09-22, do not address semaglutide salt forms or research-grade ingredients, so this record makes no Minnesota-specific claim about them; the federal 503A limits apply. [1] [6] [7] [9] [10] [11] [12]

Can you get compounded GLP-1s in Minnesota?

Regulatory: Compounded GLP-1 limited

Minnesota's statutory examination requirement in section 151.37 does not list GLP-1s, so the main state-specific checks are a Minnesota-licensed prescriber, or a physician registered for interstate telehealth under Minn. Stat. section 147.032, and a pharmacy holding a Minnesota or nonresident Minnesota license. Minnesota law does not settle whether the evaluation can happen without a live visit. [2] [3] [4] [7] [15]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Minnesota?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Minnesota

What you'll actually find in Minnesota, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [19] [20] [21]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [22]

What Minnesota has done

PeptideAgent has not found a board or legislative action on peptides in Minnesota.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [24] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [25] [26] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Minnesota. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [2] [3] [4] [5] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Minnesota Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [23]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [22]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [13] [27] [28]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [23] [29] [30]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [21] [30] [31]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [22] [32] [33] [34] [35] [36]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [22]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [23]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [21]
  • Pharmacy: Is this made for me on a prescription written in my name? [31]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [21] [30]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [21]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Minnesota?

Minn. Stat. section 151.34 prohibits manufacturing, selling, or delivering adulterated or misbranded drugs and selling legend drugs without a prescription in Minnesota. [8] [16]

Peptide-specific notes for Minnesota

Peptide-specific notes for Minnesota
PeptideNote
SemaglutideAvailable branded by prescription, including by telehealth; it is not one of the drugs for which Minn. Stat. section 151.37 requires a documented examination. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [2] [15]

Frequently asked questions

Does Minnesota require an exam before a telehealth GLP-1 prescription?

Not by a specific statute. Minn. Stat. section 151.37 requires a documented examination only for listed drugs such as controlled substances, muscle relaxants, butalbital products, and PDE5 inhibitors for erectile dysfunction. GLP-1s are not on that list, so the prescriber decides what evaluation the standard of care requires. Minnesota law does not settle whether that evaluation can happen without a live visit. The telehealth definition first describes real-time audio and video and then says telehealth includes store-and-forward technology, and nothing says which controls. [2] [3] [5]

Can an out-of-state doctor treat me in Minnesota by telehealth?

Only if the doctor holds a Minnesota license or an interstate telehealth registration with the Minnesota Board of Medical Practice under Minn. Stat. section 147.032. [4]

Can an out-of-state pharmacy ship compounded peptides to me in Minnesota?

Only if it holds a Minnesota nonresident pharmacy license under Minn. Stat. section 151.19. Search the Board of Pharmacy license lookup before ordering. [1] [7]

Can a Minnesota pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Minnesota has no state bulks list; peptide eligibility follows the federal 503A framework. [12] [13] [14] [17] [18]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Minnesota Board of Pharmacy
  2. [2]Minnesota Statutes section 151.37, Legend drugs; who may prescribe, possess
  3. [3]Minnesota Statutes section 62A.673, Coverage of services provided through telehealth (Minnesota Telehealth Act)
  4. [4]Minnesota Statutes section 147.032, Interstate practice of telemedicine
  5. [5]Minnesota Statutes section 147.033, Practice of telehealth
  6. [6]Minnesota Statutes chapter 151, Pharmacy Practice and Wholesale Distribution Act
  7. [7]Minnesota Statutes section 151.19, Pharmacy licensure requirements (including nonresident pharmacies)
  8. [8]Minnesota Statutes section 151.34, Prohibited acts
  9. [9]Minnesota Rules chapter 6800, Pharmacy and pharmacists
  10. [10]Minnesota Board of Pharmacy: guidance documents

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Minnesota?. https://peptideagent.ai/legal/minnesota
HTML link
<a href="https://peptideagent.ai/legal/minnesota">Are peptides legal in Minnesota?</a>, PeptideAgent, updated October 28, 2026.